HIV/HBV/HCV Test Kits Market
The growing trend of combination testing will play an important role in driving the growth of the HIV/HBV/HCV test kits market.
HIV/HBV/HCV Test Kits Market by Kit Types, Sample Type, End User & Region | Forecast 2023 to 2033
HIV/HBV/HCV Test Kits Market Outlook
The HIV/HBV/HCV test kits market size is projected to be valued at US$ 6,568.3 million in 2023 and is expected to rise to US$ 11,573.9 million by 2033. The sales of HIV/HBV/HCV test kits are expected to grow at a significant CAGR of 5.8% during the forecast period. Various trend positively influencing the HIV/HBV/HCV test kits market are:
A wide range of micro and macroeconomic factors are influencing the growth of the HIV/HBV/HCV test kits market. The most influential factor is the extensive awareness campaigns carried out by various non-governmental organizations around the world.
These non-governmental organizations are attempting to reach out to people in remote areas and educate them about immunodeficiency diseases and the methods for detecting and preventing them. This has resulted in a significant increase in global demand for HIV/HBV/HCV test kits.
One of the key development factors for the global HIV/HBV/HCV test kits market is rising demand for point-of-care testing for HIV, HBV, and HCV.
POC testing technologies are now more efficient, widely available, and reasonably priced. Early HIV detection can be extremely beneficial to the patient because it facilitates the doctor to design a more effective treatment plan.
Governments and regulating authorities all over the world have launched initiatives and campaigns to educate and treat people. They are supplying these kits for free in order to raise awareness.
Increasing investments by leading players to make these HIV/HBV/HCV test kits more efficient, reliable, and affordable has contributed to the global market's overall growth. The ease of use of these test kits has increased their popularity in medical centers and hospitals.
Regardless of the various factors influencing the growth of this market, there are several key issues that must be addressed in order to facilitate future growth. The relatively high total costs of developing and using HIV/HBV/HCV test kits, as well as reimbursement policies, are limiting the market's growth.
However, the market is expanding as a result of rising product approvals, alliances, and acquisitions by major companies.
|
Attributes |
Details |
|
HIV/HBV/HCV Test Kits Market CAGR |
5.8 % |
|
HIV/HBV/HCV Test Kits Market Valuation (2023) |
US$ 6,568.3 million |
|
HIV/HBV/HCV Test Kits Market Valuation (2033) |
US$ 11,573.9 million 2033 |
Let us know your requirement to get
100% FREE customization
How The Market Progressed till June 2022?
|
Market Statistics |
Details |
|
H1,2021 (A) |
6.54% |
|
H1,2022 Projected (P) |
6.44% |
|
H1,2022 Outlook (O) |
6.24% |
|
BPS Change: H1,2022 (O) - H1,2022 (P) |
(-) 20 ↓ |
|
BPS Change: H1,2022 (O) - H1,2021 (A) |
(-) 30 ↓ |
The comparative analysis and market growth rate of global HIV/HBV/HCV test kits market as studied by Future Market Insights, will show a negative BPS growth in H1-2022 outlook as compared to H1-2022 projected period by 20 BPS. Furthermore, a negative BPS growth is expected in H1-2022 over H1- 2021 duration with 30 Basis Point Share (BPS).
The decline in the BPs values observed can be attributed to the disruptions in supply chain and distribution networks globally due to the global pandemic. Moreover, the availability of self-test kits is limited to the developed nations, and thus poses a dip in demand, owed to the high disease epidemiology in the developing nations and the high demand generated through the same.
The key developments in the market include the launch of a real-time fluorescence PCR technology used for nucleic acid qualitative detection of HBV, and chip-based assays for HCV, such as the Truenat HCV.
Growing disease epidemiology of viral and infectious diseases, and the increasing efforts by regional governments to extend outreach for detection is anticipated to provide a positive growth outlook for the market during the projected period.
2018 to 2022 HIV/HBV/HCV Test Kits Market Outlook in Comparison to 2023 to 2033 Growth Forecast
The world has seen significant increase in incidence of HIV and hepatitis, and this is expected to majorly drive HIV/HBV/HCV test kit consumption. With HIV and hepatitis infections being a major public health issue across the world, demand for efficient diagnostic services for these diseases is prominent.
Sales of HIV/HBV/HCV test kits rose at a CAGR of 6.8% from 2018 to 2022. Governments and NGOs across the world are taking initiatives to raise awareness about STD testing and its importance in the fight against HIV and hepatitis. This has led to substantial increase in awareness on a global level, with initiatives such as 'Start Talking. Stop HIV'.
Rising research & developments in the medical diagnostics industry, increasing incidence of HIV and hepatitis, increasing awareness among the general population, rising healthcare expenditure, technological advancements in diagnostics, etc., are some major factors that are expected to drive consumption of HIV/HBV/HCV test kits.
Demand for HIV/HBV/HCV test kits is expected to be majorly influenced by developing and emerging markets, with low- and middle-income countries such as Brazil, India, and China leading the way.
Lack of awareness and inadequate availability of test kits in less-developed economies is expected to restrain demand for HIV/HBV/HCV test kits to a certain extent. Market witnessed a significant downfall during the pandemic period as supply lines were cut short. Nevertheless, the market is anticipated to recover swiftly and contribute a US$ 11,573.9 million revenue share by 2033.
Overall, the HIV/HBV/HCV test kits market is predicted to expand at a CAGR of 5.8% from 2023 to 2033.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhich Key Trends are Expected to Majorly Influence Demand for HIV/HBV/HCV Test Kits?
Innovations and Product developments
The burden of HIV, HBV, and HCV infections is still disproportionately high in developing economies (India, sub-Saharan Africa, Brazil) where co-infection rates are high. For HIV, HBV, and HCV serological testing, high analytical performance multiplex rapid diagnostic techniques may improve the cascade of screening and lead to more cost-effective linkage to care. Such a testing strategy may be especially beneficial for hard-to-reach high-risk populations and may also increase the impact of self-testing on public health. For instance, the prototype Triplex HIV/HCV/HBsAg finger-stick whole-blood self-test may provide a simple, quick, and inexpensive way to detect HIV, HBV, and HCV infections. It might be particularly useful for enhancing the detection of three closely related endemic viral diseases. These choices might boost screening programs, reducing the price of diseases brought on by untreated HIV, HBV, or HCV infections in the future. They might also help with efforts to treat these infections and perhaps even eradicate HCV infection.
Which Restraining Factors Could Impede Market Growth?
Lack of Awareness to Hinder Sales of HIV Test Kits
Awareness about the treatment of HIV in less developed economies such as Brazil, India, and African nations is very limited due to lack of developed healthcare infrastructure. This has adversely affected HIV/HBV/HCV test kit sales in these economies and restrained overall market potential on a global level.
The asymptomatic nature of infections has also hampered the HIV/HBV/HCV test kits market. Poor healthcare facilities, high costs of treatments and medicines, and low STD testing are some other factors that may restrain HIV test kit sales over the forecast period.
A unified Market Research Subscription Platform, built for today's disparate research needs.
Comparative view of HIV/HBV/HCV Test Kits Market
HIV/HBV/HCV Test Kits Market:
|
Attributes |
HIV/HBV/HCV Test Kits Market |
|
CAGR (2023 to 2033) |
5.8% |
|
Market Value (2033) |
US$ 11,573.9 million |
|
Growth Factor |
The rising prevalence of chronic diseases, as well as technological innovations and advancements in screening procedures, are driving market growth. |
|
Opportunity |
Increased public awareness, increased government cancer-fighting initiatives, and rising healthcare costs are expected to drive the market forward. |
Low dosage Hydrate Inhibitors Market:
|
Attributes |
Low dosage Hydrate Inhibitors Market |
|
CAGR (2023 to 2033) |
8.1% |
|
Market Value (2033) |
US$ 127.45 million. |
|
Growth Factor |
Low dosage hydrate inhibitors' ability to reduce transportation and handling costs through decreased delivery frequency and chemical consumption is expected to drive market sales. |
|
Opportunity |
Increased crude oil exploration and production are expected to drive market growth, as low dosage hydrate inhibitors are widely used in extraction processes to reduce hydrate formation in the systems. |
Kinase Inhibitors for Cancer Treatment Market:
|
Attributes |
Kinase Inhibitors for Cancer Treatment Market |
|
CAGR (2023 to 2033) |
10.5% |
|
Market Value (2033) |
US$ 122,133.64 million |
|
Growth Factor |
Pharmaceutical companies are currently investing heavily in R&D to develop improved kinase inhibitors. This is currently propelling market growth. |
|
Opportunity |
Massive technological advancements are taking place in the healthcare sector, particularly in the field of cancer treatment. |
Country-wise Analysis
Growing preference for rapid screening is anticipated to stimulate sales of rapid HIV test kits in the country.
HIV has been a public health issue in the United States for quite some time, and while the number of new cases has decreased over the past decades, the rate of new infection detections remains a source of concern. Advanced healthcare infrastructure, increased patient awareness, and rising adoption of effective rapid testing kits are some of the major factors driving the HIV/HBV/HCV testing systems market in the United States.
|
United States Market Size (US$million/billion) by End of Forecast Period (2033) |
US$ 3,455 million |
|
United States Market Absolute Dollar Growth (US$ million/billion) |
US$ 135.1 million |
|
CAGR % 2017 to 2022 |
7.7% |
|
CAGR % 2023 to End of Forecast (2033) |
5.9% |
Canada is expected to account for US$ 479.0 million of the North American HIV/HBV/HCV Test Kits market.
Canada is expected to have a significant share due to advanced diagnostic tools, high awareness of disease and diagnostic devices, a strong presence of industry players in the region, improved healthcare infrastructure, and increased awareness among healthcare industry stakeholders about available technologies in the region. For example, the Public Health Agency of Canada investigated 28 cases of severe acute hepatitis in children in Canada that met the national case definition between April and September 2022. As a result, an increase in hepatitis cases is expected to lead to an increase in diagnostic testing, ultimately driving market growth in the region.
|
Canada Market Size (US$ million/billion) by End of Forecast Period (2033) |
US$ 479.0 million |
|
Canada Market Absolute Dollar Growth (US$ million/billion) |
21.70 million |
|
CAGR % 2017 to 2022 |
9.1% |
|
CAGR % 2023 to End of Forecast (2033) |
6.4% |
Over the next few years, the Asia Pacific market for HIV/HBV/HCV test kits is expected to grow rapidly.
The region's ever-increasing population is the primary driving factor for the market. China and India are two of the world's most densely populated countries in Asia Pacific. A dense population is more likely to be infected with an immunodeficiency virus. Naturally, awareness and availability of HIV/HBV/HCV test kits are expected to grow in the Asia Pacific market.
|
China Market Size (US$ million/billion) by End of Forecast Period (2033) |
US$ 1032.4 million |
|
China Market Absolute Dollar Growth (US$ million/billion) |
US$ 28.4 million |
|
CAGR % 2017 to 2022 |
3.8% |
|
CAGR % 2023 to End of Forecast (2033) |
5.5% |
India is the world's second-most populous country and ranks third in terms of HIV infections, with over 2 million people infected. Instances of new HIV infections have decreased in recent decades, but they remain a source of concern given the country's large population.
Increasing STD testing awareness and developing healthcare infrastructure are expected to have a significant impact on HIV/HBV/HCV test equipment demand in India. Over the next few years, the market in India is likely to remain extremely profitable for HIV/HBV/HCV test kit providers.
HIV/HBV/HCV Test Kits Market - Category-wise Insights
Relative to conventional testing, assays have been proved to deliver reliable results, even with microscopic samples.
Segment to witness a growth of 6.4% during 2023 to 2033
In 2022, the assay-based test kits segment held the major share of the market. Assay kits are the first line of patients testing which is naturally stimulating its growth. Furthermore, in most developing countries, healthcare professionals and patients rely on assay-based testing results. Besides, there have been advancements in assay-based test kits. The Xpert HCV Viral Load Fingerstick Test from Cepheid, for example, is a point-of-care test that employs the GeneXpert System. This point-of-care test looks for HCV RNA in finger-stick whole blood capillaries (or assay). This type of HCV testing involves drawing capillary blood from the patient via finger prick into a Minivette collection device, which is then processed in a GeneXpert device at or near the point-of-care testing location.
Blood sample tops the sample segment and is expanding at a rapid rate of 6.1% CAGR during the forecast period.
Blood samples are highly prevalent in testing or diagnosis procedures due to ease in storing and their high reliability on patients sample profile. Most AIDS and AIDS-related complex (ARC) patients, as well as many asymptomatic individuals belonging to high-risk groups, have been found to have antibodies to the human immunodeficiency virus (HIV). The presence of these HIV antibodies in human blood and plasma samples is frequently tested using enzyme-linked immunosorbent assays (ELISA). INNO-LIA HIV I/II Score, for example, is a Line Immuno Assay (LIA) that detects the presence of antibodies against HIV-1, including group O and HIV-2, in human blood or plasma. INNO-HIV LIA's I/II Score distinguishes between HIV-1 and HIV-2 infections. It is intended to be used in conjunction with an anti-HIV screening process on reactive specimens. As a result, demand for assay-based test kits has increased.
Competitive Landscape
Given the presence of a few companies operating globally and regionally, the HIV/HBV/HCV test market is slightly fragmented. The competitive landscape includes an examination of a few well-known international and local companies that hold market share. Abbott Laboratories, Danaher Corporation, BioMerieux SA, Bio-Rad Laboratories Inc, Diasorin S.p.A, F. Hoffmann-La Roche AG, Hologic Inc, MedMira Inc, Qaigen Inc, Grifols SA, Sysmex Corporation, and Siemens Healthineers are key market players.
- Gilead Sciences, Inc. joined a public-private partnership with the Partnership for Health Advancement in Vietnam (HAIVN), a collaboration of Brigham and Women's Hospital, Harvard Medical School, and Beth Israel Deaconess Medical Center, in September 2022. The multi-year initiative to take a phased approach to addressing barriers to viral hepatitis diagnosis and care in primary healthcare institutions in Vietnam and the Philippines, both of which have high hepatitis B and C burdens.
- Roche introduced the Elecsys HCV Duo immunoassay in July 2022. Elecsys HCV Duo is one of the first commercially available immunoassays that can determine hepatitis C virus (HCV) antigen and antibody status simultaneously and independently.
Scope of Report
|
Attribute |
Details |
|
Forecast Period |
2023 to 2033 |
|
Historical Data Available for |
2018 to 2022 |
|
Market Analysis |
US$ million for Value |
|
Key Countries Covered |
USA, Canada, Germany, United Kingdom, France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, and South Africa |
|
Key Segments Covered |
|
|
Key Companies Profiled |
BioMerieux SA, Bio-Rad Laboratories Inc, Diasorin S.p.A, F. Hoffmann-La Roche AG, Hologic Inc, MedMira Inc, Qaigen Inc, Grifols SA, Sysmex Corporation, and Siemens Healthineers |
|
Report Coverage |
Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
|
Customization & Pricing |
Available upon Request |
HIV/HBV/HCV Test Kits Market by Solution
HIV/HBV/HCV Test Kits Market by Test Kit Type:
- Assay-based Test Kits
- Rapid Test Kits
HIV/HBV/HCV Test Kits Market by Sample:
- Blood
- Urine
- Saliva
HIV/HBV/HCV Test Kits Market by End User:
- HIV/HBV/HCV Test Kits for Hospitals
- HIV/HBV/HCV Test Kits for Clinics
- HIV/HBV/HCV Test Kits for Diagnostic Laboratories
- HIV/HBV/HCV Test Kits for Government Organizations and NGOs
- Others
By Region:
- North America
- Latin America
- Europe
- South Asia & Pacific
- East Asia
- Middle East & Africa (MEA)
Frequently Asked Questions
How is the HIV/HBV/HCV Test Kits Market Growing?
The HIV/HBV/HCV Test Kits market is predicted to grow at 5.8% CAGR through 2023-2033.
What Drives the HIV/HBV/HCV Test Kits Market?
High prevalence of chronic diseases and lack of awareness.
What is the Future Scope of Growth for the HIV/HBV/HCV Test Kits Market?
The HIV/HBV/HCV Test Kits market is expected to surpass US$ 11,53.9 million by 2033.
What is the Current HIV/HBV/HCV Test Kits Market Size?
The HIV/HBV/HCV Test Kits market size is anticipated to be US$ 6,568.3 million in 2033.
Table of Content
1. Executive Summary | HIV/HBV/HCV Test Kits Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Test Kit Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Test Kit Type, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Test Kit Type, 2023 to 2033 5.3.1. Assay-based Test Kits 5.3.2. Rapid Test Kits 5.4. Y-o-Y Growth Trend Analysis By Test Kit Type, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Test Kit Type, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Sample 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Sample, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Sample, 2023 to 2033 6.3.1. Blood 6.3.2. Urine 6.3.3. Saliva 6.4. Y-o-Y Growth Trend Analysis By Sample, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Sample, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By End User , 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User , 2023 to 2033 7.3.1. Hospitals 7.3.2. Clinics 7.3.3. Diagnostic Laboratories 7.3.4. Government Organizations and NGOs 7.3.5. Others 7.4. Y-o-Y Growth Trend Analysis By End User , 2018 to 2022 7.5. Absolute $ Opportunity Analysis By End User , 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. Asia Pacific 8.3.5. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. USA 9.2.1.2. Canada 9.2.2. By Test Kit Type 9.2.3. By Sample 9.2.4. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Test Kit Type 9.3.3. By Sample 9.3.4. By End User 9.4. Key Takeaways 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Test Kit Type 10.2.3. By Sample 10.2.4. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Test Kit Type 10.3.3. By Sample 10.3.4. By End User 10.4. Key Takeaways 11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. United Kingdom 11.2.1.2. Spain 11.2.1.3. Germany 11.2.1.4. Italy 11.2.1.5. France 11.2.1.6. Rest of Europe 11.2.2. By Test Kit Type 11.2.3. By Sample 11.2.4. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Test Kit Type 11.3.3. By Sample 11.3.4. By End User 11.4. Key Takeaways 12. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. China 12.2.1.2. Japan 12.2.1.3. India 12.2.1.4. South Korea 12.2.1.5. Rest of Asia Pacific 12.2.2. By Test Kit Type 12.2.3. By Sample 12.2.4. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Test Kit Type 12.3.3. By Sample 12.3.4. By End User 12.4. Key Takeaways 13. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. South Africa 13.2.1.2. GCC Countries 13.2.1.3. Rest of Middle East and Africa 13.2.2. By Test Kit Type 13.2.3. By Sample 13.2.4. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Test Kit Type 13.3.3. By Sample 13.3.4. By End User 13.4. Key Takeaways 14. Key Countries Market Analysis 14.1. USA 14.1.1. Pricing Analysis 14.1.2. Market Share Analysis, 2022 14.1.2.1. By Test Kit Type 14.1.2.2. By Sample 14.1.2.3. By End User 14.2. Canada 14.2.1. Pricing Analysis 14.2.2. Market Share Analysis, 2022 14.2.2.1. By Test Kit Type 14.2.2.2. By Sample 14.2.2.3. By End User 14.3. Brazil 14.3.1. Pricing Analysis 14.3.2. Market Share Analysis, 2022 14.3.2.1. By Test Kit Type 14.3.2.2. By Sample 14.3.2.3. By End User 14.4. Mexico 14.4.1. Pricing Analysis 14.4.2. Market Share Analysis, 2022 14.4.2.1. By Test Kit Type 14.4.2.2. By Sample 14.4.2.3. By End User 14.5. United Kingdom 14.5.1. Pricing Analysis 14.5.2. Market Share Analysis, 2022 14.5.2.1. By Test Kit Type 14.5.2.2. By Sample 14.5.2.3. By End User 14.6. Spain 14.6.1. Pricing Analysis 14.6.2. Market Share Analysis, 2022 14.6.2.1. By Test Kit Type 14.6.2.2. By Sample 14.6.2.3. By End User 14.7. Germany 14.7.1. Pricing Analysis 14.7.2. Market Share Analysis, 2022 14.7.2.1. By Test Kit Type 14.7.2.2. By Sample 14.7.2.3. By End User 14.8. Italy 14.8.1. Pricing Analysis 14.8.2. Market Share Analysis, 2022 14.8.2.1. By Test Kit Type 14.8.2.2. By Sample 14.8.2.3. By End User 14.9. France 14.9.1. Pricing Analysis 14.9.2. Market Share Analysis, 2022 14.9.2.1. By Test Kit Type 14.9.2.2. By Sample 14.9.2.3. By End User 14.10. China 14.10.1. Pricing Analysis 14.10.2. Market Share Analysis, 2022 14.10.2.1. By Test Kit Type 14.10.2.2. By Sample 14.10.2.3. By End User 14.11. Japan 14.11.1. Pricing Analysis 14.11.2. Market Share Analysis, 2022 14.11.2.1. By Test Kit Type 14.11.2.2. By Sample 14.11.2.3. By End User 14.12. India 14.12.1. Pricing Analysis 14.12.2. Market Share Analysis, 2022 14.12.2.1. By Test Kit Type 14.12.2.2. By Sample 14.12.2.3. By End User 14.13. South Korea 14.13.1. Pricing Analysis 14.13.2. Market Share Analysis, 2022 14.13.2.1. By Test Kit Type 14.13.2.2. By Sample 14.13.2.3. By End User 14.14. South Africa 14.14.1. Pricing Analysis 14.14.2. Market Share Analysis, 2022 14.14.2.1. By Test Kit Type 14.14.2.2. By Sample 14.14.2.3. By End User 14.15. GCC Countries 14.15.1. Pricing Analysis 14.15.2. Market Share Analysis, 2022 14.15.2.1. By Test Kit Type 14.15.2.2. By Sample 14.15.2.3. By End User 15. Market Structure Analysis 15.1. Competition Dashboard 15.2. Competition Benchmarking 15.3. Market Share Analysis of Top Players 15.3.1. By Regional 15.3.2. By Test Kit Type 15.3.3. By Sample 15.3.4. By End User 16. Competition Analysis 16.1. Competition Deep Dive 16.1.1. Hoffmann-La Roche Ltd. 16.1.1.1. Overview 16.1.1.2. Product Portfolio 16.1.1.3. Profitability by Market Segments 16.1.1.4. Sales Footprint 16.1.1.5. Strategy Overview 16.1.1.5.1. Marketing Strategy 16.1.2. Abbott Laboratories 16.1.2.1. Overview 16.1.2.2. Product Portfolio 16.1.2.3. Profitability by Market Segments 16.1.2.4. Sales Footprint 16.1.2.5. Strategy Overview 16.1.2.5.1. Marketing Strategy 16.1.3. bioMérieux SA 16.1.3.1. Overview 16.1.3.2. Product Portfolio 16.1.3.3. Profitability by Market Segments 16.1.3.4. Sales Footprint 16.1.3.5. Strategy Overview 16.1.3.5.1. Marketing Strategy 16.1.4. Bio-Rad Laboratories Inc. 16.1.4.1. Overview 16.1.4.2. Product Portfolio 16.1.4.3. Profitability by Market Segments 16.1.4.4. Sales Footprint 16.1.4.5. Strategy Overview 16.1.4.5.1. Marketing Strategy 16.1.5. QIAGEN 16.1.5.1. Overview 16.1.5.2. Product Portfolio 16.1.5.3. Profitability by Market Segments 16.1.5.4. Sales Footprint 16.1.5.5. Strategy Overview 16.1.5.5.1. Marketing Strategy 16.1.6. Hologic Inc. 16.1.6.1. Overview 16.1.6.2. Product Portfolio 16.1.6.3. Profitability by Market Segments 16.1.6.4. Sales Footprint 16.1.6.5. Strategy Overview 16.1.6.5.1. Marketing Strategy 16.1.7. Meridian Bioscience, Inc. 16.1.7.1. Overview 16.1.7.2. Product Portfolio 16.1.7.3. Profitability by Market Segments 16.1.7.4. Sales Footprint 16.1.7.5. Strategy Overview 16.1.7.5.1. Marketing Strategy 16.1.8. Siemens AG 16.1.8.1. Overview 16.1.8.2. Product Portfolio 16.1.8.3. Profitability by Market Segments 16.1.8.4. Sales Footprint 16.1.8.5. Strategy Overview 16.1.8.5.1. Marketing Strategy 16.1.9. Creative Diagnostics 16.1.9.1. Overview 16.1.9.2. Product Portfolio 16.1.9.3. Profitability by Market Segments 16.1.9.4. Sales Footprint 16.1.9.5. Strategy Overview 16.1.9.5.1. Marketing Strategy 17. Assumptions & Acronyms Used 18. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033 Table 2: Global Market Value (US$ Million) Forecast by Test Kit Type, 2018 to 2033 Table 3: Global Market Value (US$ Million) Forecast by Sample, 2018 to 2033 Table 4: Global Market Value (US$ Million) Forecast by End User , 2018 to 2033 Table 5: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 6: North America Market Value (US$ Million) Forecast by Test Kit Type, 2018 to 2033 Table 7: North America Market Value (US$ Million) Forecast by Sample, 2018 to 2033 Table 8: North America Market Value (US$ Million) Forecast by End User , 2018 to 2033 Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 10: Latin America Market Value (US$ Million) Forecast by Test Kit Type, 2018 to 2033 Table 11: Latin America Market Value (US$ Million) Forecast by Sample, 2018 to 2033 Table 12: Latin America Market Value (US$ Million) Forecast by End User , 2018 to 2033 Table 13: Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 14: Europe Market Value (US$ Million) Forecast by Test Kit Type, 2018 to 2033 Table 15: Europe Market Value (US$ Million) Forecast by Sample, 2018 to 2033 Table 16: Europe Market Value (US$ Million) Forecast by End User , 2018 to 2033 Table 17: Asia Pacific Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 18: Asia Pacific Market Value (US$ Million) Forecast by Test Kit Type, 2018 to 2033 Table 19: Asia Pacific Market Value (US$ Million) Forecast by Sample, 2018 to 2033 Table 20: Asia Pacific Market Value (US$ Million) Forecast by End User , 2018 to 2033 Table 21: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 22: Middle East and Africa Market Value (US$ Million) Forecast by Test Kit Type, 2018 to 2033 Table 23: Middle East and Africa Market Value (US$ Million) Forecast by Sample, 2018 to 2033 Table 24: Middle East and Africa Market Value (US$ Million) Forecast by End User , 2018 to 2033
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: Global Market Value (US$ Million) by Test Kit Type, 2023 to 2033 Figure 2: Global Market Value (US$ Million) by Sample, 2023 to 2033 Figure 3: Global Market Value (US$ Million) by End User , 2023 to 2033 Figure 4: Global Market Value (US$ Million) by Region, 2023 to 2033 Figure 5: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033 Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033 Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033 Figure 8: Global Market Value (US$ Million) Analysis by Test Kit Type, 2018 to 2033 Figure 9: Global Market Value Share (%) and BPS Analysis by Test Kit Type, 2023 to 2033 Figure 10: Global Market Y-o-Y Growth (%) Projections by Test Kit Type, 2023 to 2033 Figure 11: Global Market Value (US$ Million) Analysis by Sample, 2018 to 2033 Figure 12: Global Market Value Share (%) and BPS Analysis by Sample, 2023 to 2033 Figure 13: Global Market Y-o-Y Growth (%) Projections by Sample, 2023 to 2033 Figure 14: Global Market Value (US$ Million) Analysis by End User , 2018 to 2033 Figure 15: Global Market Value Share (%) and BPS Analysis by End User , 2023 to 2033 Figure 16: Global Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033 Figure 17: Global Market Attractiveness by Test Kit Type, 2023 to 2033 Figure 18: Global Market Attractiveness by Sample, 2023 to 2033 Figure 19: Global Market Attractiveness by End User , 2023 to 2033 Figure 20: Global Market Attractiveness by Region, 2023 to 2033 Figure 21: North America Market Value (US$ Million) by Test Kit Type, 2023 to 2033 Figure 22: North America Market Value (US$ Million) by Sample, 2023 to 2033 Figure 23: North America Market Value (US$ Million) by End User , 2023 to 2033 Figure 24: North America Market Value (US$ Million) by Country, 2023 to 2033 Figure 25: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 28: North America Market Value (US$ Million) Analysis by Test Kit Type, 2018 to 2033 Figure 29: North America Market Value Share (%) and BPS Analysis by Test Kit Type, 2023 to 2033 Figure 30: North America Market Y-o-Y Growth (%) Projections by Test Kit Type, 2023 to 2033 Figure 31: North America Market Value (US$ Million) Analysis by Sample, 2018 to 2033 Figure 32: North America Market Value Share (%) and BPS Analysis by Sample, 2023 to 2033 Figure 33: North America Market Y-o-Y Growth (%) Projections by Sample, 2023 to 2033 Figure 34: North America Market Value (US$ Million) Analysis by End User , 2018 to 2033 Figure 35: North America Market Value Share (%) and BPS Analysis by End User , 2023 to 2033 Figure 36: North America Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033 Figure 37: North America Market Attractiveness by Test Kit Type, 2023 to 2033 Figure 38: North America Market Attractiveness by Sample, 2023 to 2033 Figure 39: North America Market Attractiveness by End User , 2023 to 2033 Figure 40: North America Market Attractiveness by Country, 2023 to 2033 Figure 41: Latin America Market Value (US$ Million) by Test Kit Type, 2023 to 2033 Figure 42: Latin America Market Value (US$ Million) by Sample, 2023 to 2033 Figure 43: Latin America Market Value (US$ Million) by End User , 2023 to 2033 Figure 44: Latin America Market Value (US$ Million) by Country, 2023 to 2033 Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 48: Latin America Market Value (US$ Million) Analysis by Test Kit Type, 2018 to 2033 Figure 49: Latin America Market Value Share (%) and BPS Analysis by Test Kit Type, 2023 to 2033 Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Test Kit Type, 2023 to 2033 Figure 51: Latin America Market Value (US$ Million) Analysis by Sample, 2018 to 2033 Figure 52: Latin America Market Value Share (%) and BPS Analysis by Sample, 2023 to 2033 Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Sample, 2023 to 2033 Figure 54: Latin America Market Value (US$ Million) Analysis by End User , 2018 to 2033 Figure 55: Latin America Market Value Share (%) and BPS Analysis by End User , 2023 to 2033 Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033 Figure 57: Latin America Market Attractiveness by Test Kit Type, 2023 to 2033 Figure 58: Latin America Market Attractiveness by Sample, 2023 to 2033 Figure 59: Latin America Market Attractiveness by End User , 2023 to 2033 Figure 60: Latin America Market Attractiveness by Country, 2023 to 2033 Figure 61: Europe Market Value (US$ Million) by Test Kit Type, 2023 to 2033 Figure 62: Europe Market Value (US$ Million) by Sample, 2023 to 2033 Figure 63: Europe Market Value (US$ Million) by End User , 2023 to 2033 Figure 64: Europe Market Value (US$ Million) by Country, 2023 to 2033 Figure 65: Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 66: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 67: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 68: Europe Market Value (US$ Million) Analysis by Test Kit Type, 2018 to 2033 Figure 69: Europe Market Value Share (%) and BPS Analysis by Test Kit Type, 2023 to 2033 Figure 70: Europe Market Y-o-Y Growth (%) Projections by Test Kit Type, 2023 to 2033 Figure 71: Europe Market Value (US$ Million) Analysis by Sample, 2018 to 2033 Figure 72: Europe Market Value Share (%) and BPS Analysis by Sample, 2023 to 2033 Figure 73: Europe Market Y-o-Y Growth (%) Projections by Sample, 2023 to 2033 Figure 74: Europe Market Value (US$ Million) Analysis by End User , 2018 to 2033 Figure 75: Europe Market Value Share (%) and BPS Analysis by End User , 2023 to 2033 Figure 76: Europe Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033 Figure 77: Europe Market Attractiveness by Test Kit Type, 2023 to 2033 Figure 78: Europe Market Attractiveness by Sample, 2023 to 2033 Figure 79: Europe Market Attractiveness by End User , 2023 to 2033 Figure 80: Europe Market Attractiveness by Country, 2023 to 2033 Figure 81: Asia Pacific Market Value (US$ Million) by Test Kit Type, 2023 to 2033 Figure 82: Asia Pacific Market Value (US$ Million) by Sample, 2023 to 2033 Figure 83: Asia Pacific Market Value (US$ Million) by End User , 2023 to 2033 Figure 84: Asia Pacific Market Value (US$ Million) by Country, 2023 to 2033 Figure 85: Asia Pacific Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 86: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 87: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 88: Asia Pacific Market Value (US$ Million) Analysis by Test Kit Type, 2018 to 2033 Figure 89: Asia Pacific Market Value Share (%) and BPS Analysis by Test Kit Type, 2023 to 2033 Figure 90: Asia Pacific Market Y-o-Y Growth (%) Projections by Test Kit Type, 2023 to 2033 Figure 91: Asia Pacific Market Value (US$ Million) Analysis by Sample, 2018 to 2033 Figure 92: Asia Pacific Market Value Share (%) and BPS Analysis by Sample, 2023 to 2033 Figure 93: Asia Pacific Market Y-o-Y Growth (%) Projections by Sample, 2023 to 2033 Figure 94: Asia Pacific Market Value (US$ Million) Analysis by End User , 2018 to 2033 Figure 95: Asia Pacific Market Value Share (%) and BPS Analysis by End User , 2023 to 2033 Figure 96: Asia Pacific Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033 Figure 97: Asia Pacific Market Attractiveness by Test Kit Type, 2023 to 2033 Figure 98: Asia Pacific Market Attractiveness by Sample, 2023 to 2033 Figure 99: Asia Pacific Market Attractiveness by End User , 2023 to 2033 Figure 100: Asia Pacific Market Attractiveness by Country, 2023 to 2033 Figure 101: Middle East and Africa Market Value (US$ Million) by Test Kit Type, 2023 to 2033 Figure 102: Middle East and Africa Market Value (US$ Million) by Sample, 2023 to 2033 Figure 103: Middle East and Africa Market Value (US$ Million) by End User , 2023 to 2033 Figure 104: Middle East and Africa Market Value (US$ Million) by Country, 2023 to 2033 Figure 105: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 106: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 107: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 108: Middle East and Africa Market Value (US$ Million) Analysis by Test Kit Type, 2018 to 2033 Figure 109: Middle East and Africa Market Value Share (%) and BPS Analysis by Test Kit Type, 2023 to 2033 Figure 110: Middle East and Africa Market Y-o-Y Growth (%) Projections by Test Kit Type, 2023 to 2033 Figure 111: Middle East and Africa Market Value (US$ Million) Analysis by Sample, 2018 to 2033 Figure 112: Middle East and Africa Market Value Share (%) and BPS Analysis by Sample, 2023 to 2033 Figure 113: Middle East and Africa Market Y-o-Y Growth (%) Projections by Sample, 2023 to 2033 Figure 114: Middle East and Africa Market Value (US$ Million) Analysis by End User , 2018 to 2033 Figure 115: Middle East and Africa Market Value Share (%) and BPS Analysis by End User , 2023 to 2033 Figure 116: Middle East and Africa Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033 Figure 117: Middle East and Africa Market Attractiveness by Test Kit Type, 2023 to 2033 Figure 118: Middle East and Africa Market Attractiveness by Sample, 2023 to 2033 Figure 119: Middle East and Africa Market Attractiveness by End User , 2023 to 2033 Figure 120: Middle East and Africa Market Attractiveness by Country, 2023 to 2033
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
